ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1943

Virtual Rheumatology in the Real World: Use of Telemonitoring to Optimize the Management of Patients with Rheumatoid Arthritis

Maria Di Cicco1, Elisa Verduci1, Marina Muscarà1, Laura Belloli1, Antonella Adinolfi1, Cinzia Casu1, Davide Filippini1, Federica Filippini2, Maria Chiara Gerardi1, Martina Schettino1, Nicola Ughi3 and Oscar Massimiliano Epis1, 1Niguarda Hospital, Milan, Milan, Italy, 2Bicocca University, Milan, Italy, 3Niguarda Hospital, Milan, Mila, Italy

Meeting: ACR Convergence 2024

Keywords: Access to care, Patient reported outcomes, rheumatoid arthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 18, 2024

Title: Health Services Research – ACR/ARP Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: The burden of chronic musculoskeletal disease is increasing worldwide, with a high demand for innovative approaches to deliver effective, feasible and cost-effective access to care. With specific regard to rheumatoid arthritis (RA),  self-reported data from patients collected remotely (ePROs= electronic patient reported outcomes) have the potential to improve healthcare services. Indeed, according to EULAR/ACR,  PROs could act as a valid surrogate for disease activity measures and enable effective tight control in patients with RA, allowing early identification of disease flares, prioritization of patients who require early treatment review, and reducing appointment frequency for those in stable remission/low disease activity.

Methods: 150 patients over 18 year of age, with a diagnosis of RA according to the 1987 or 2010 classification criteria, undergoing synthetic DMARD therapy and with low/ moderate disease activity according to DAS28, have been encouraged to upload  ePROS on a dedicated online platform on a monthly basis for 12 months, after receiving adequate training. The information collected on the online platform was available to the clinical team for regular monitoring.  Each patient was allocated a follow-up appointment after 6 months of telemonitoring. Among the ePROs, RADAI (Rheumatoid Activity Disease Activity Index) is a self-administered questionnaire that correlates with validated composite measures of disese activity such as DAS28. RADAI asks patients to rate pain in eight joint areas (total score range 0-48; 0-2.8=remission: 2.9-10 low disease activity; 10.1-22 moderate; > 22 high disease activity). Patients in remission/low disease activity within 2 months prior the scheduled visit at 6 months were offered to have their appointment postponed to 12 months. A satisfaction questionnaire was collected at the end of the 12 months.

Results: Mean age 61 ( ± 11 SD , min age 22 max age 85). Female 106 (70%)

We considered 4 different outcomes:
Outcome 1 = 47 (31.3%) the visit planned at 6 months was postponed to 12 months

Outcome 2 = 27 (18%) the visit at 6 months was not postponed due to active disease

Outcome 3 = 55 (36.7%) ePROs were not uploaded due to lack of compliance

Outcome 4= 21 (14%) ePROs were not uploaded due to technical issues/lack of confidence with the electronic system on the patients’ side

A significant difference among the 4 groups by age has been observed (p value 0.02, Kruskal -Wallis test). Post -hoc test (using the Holm correction to adjust p) showed that the only significant difference between groups when compared one to one was between goup 1 and group 4 (mean age in group 1 being the lowest and in group 4 being the highest) .

128 patients answered the satisfaction questionnaire: 55% were very satisfied, 75% stated  telemonitoring would be an important asset for heathcare in future.

Conclusion: Telemonitoring enabled the postponement of pre-scheduled visits for patients in remission/low disease activity, avoiding unecessary journeys to the hospital for these patients and freeing slots/cutting waiting lists for patients in need to be seen. Our project shows a relevant age divide, with younger patients being more confident with the use of ePROs and more likely to benefit from telemedicine.


Disclosures: M. Di Cicco: None; E. Verduci: None; M. Muscarà: None; L. Belloli: None; A. Adinolfi: None; C. Casu: None; D. Filippini: None; F. Filippini: None; M. Gerardi: None; M. Schettino: None; N. Ughi: None; O. Epis: None.

To cite this abstract in AMA style:

Di Cicco M, Verduci E, Muscarà M, Belloli L, Adinolfi A, Casu C, Filippini D, Filippini F, Gerardi M, Schettino M, Ughi N, Epis O. Virtual Rheumatology in the Real World: Use of Telemonitoring to Optimize the Management of Patients with Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/virtual-rheumatology-in-the-real-world-use-of-telemonitoring-to-optimize-the-management-of-patients-with-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/virtual-rheumatology-in-the-real-world-use-of-telemonitoring-to-optimize-the-management-of-patients-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology